American Renal Associates Holdings (American Renal Associates Holdings) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2020)

View and export this data going back to 2016. Start your Free Trial

What is American Renal Associates Holdings 3-Year Dividend Growth Rate?

American Renal Associates Holdings's Dividends per Share for the three months ended in Sep. 2020 was $0.00.

The historical rank and industry rank for American Renal Associates Holdings's 3-Year Dividend Growth Rate or its related term are showing as below:

ARA's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 10.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

American Renal Associates Holdings's Dividend Payout Ratio for the three months ended in Sep. 2020 was 0.00. As of today, American Renal Associates Holdings's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of American Renal Associates Holdings's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, American Renal Associates Holdings's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Renal Associates Holdings's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, American Renal Associates Holdings's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where American Renal Associates Holdings's 3-Year Dividend Growth Rate falls into.

American Renal Associates Holdings 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

American Renal Associates Holdings (NYSE:ARA) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

American Renal Associates Holdings's Dividend Payout Ratio for the quarter that ended in Sep. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2020 )	/	EPS without NRI (Q: Sep. 2020 )
	=	0	/	-0.08
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Renal Associates Holdings 3-Year Dividend Growth Rate Related Terms>

American Renal Associates Holdings (American Renal Associates Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » American Renal Associates Holdings Inc (NYSE:ARA) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 6550, Beverly, MA, USA, 01915

Website

https://www.americanrenal.com

American Renal Associates Holdings Inc is a joint venture-focused dialysis services provider in the United States. The company through its subsidiary is engaged in providing kidney dialysis services for patients suffering from chronic kidney failure, also known as end-stage renal disease. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure.

Executives

Don E Williamson	officer: EVP, Chief Operating Officer	500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915
Victoria Labriola	officer: VP and General Counsel	AMERICAN RENAL HOLDINGS, INC. 500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915
Joseph A Carlucci	director, officer: Chief Executive Officer	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Syed T Kamal	director, officer: President	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Jeremy Gelber	director	C/O CENTERBRIDGE PARTNERS, L.P., 375 PARK AVE, 12TH FLOOR, NEW YORK NY 10152
Christopher J Hocevar	director	1601 CHESTNUT STREET SHAREHOLDER SERVICES TL05Y PHILADELPHIA PA 19192
Robert H Fish	director	C/O SKILLED HEALTHCARE 27442 PORTOLA PARKWAY, SUITE 200 FOOTHILL RANCH CA 92610
Michael Boxer	director	9151 BOULEVARD 26 NORTH RICHLAND HILLS TX 76180
John M Jureller	director	FRONTIER COMMUNICATIONS, 401 MERRITT 7, NORWALK CT 06851
Thomas W Erickson	director	OMEGA HEALTHCARE INVESTORS INC, 900 VICTORS WAY STE. 350, AMM ARBER MI 48108
Jason Boucher	officer: Former VP & CFO	500 CUMMINGS CENTER SUITE 6550 BEVERLY MA 01915
Mark Herbers	officer: Interim CFO and Interim CAO	500 CUMMINGS CENTER, SUITE 6550, BEVERLY MA 01915
Michael Ray Costa	officer: VP and General Counsel	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Patrick T Ryan	director	401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Jonathan L Wilcox	officer: VP & Chief Financial Officer	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915